v3.26.3
Segment Information
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
(16) Segment Information
The Company operates as a single operating segment, which is the business of developing, manufacturing and distributing chemical, biological and biorational products for agricultural, commercial and consumer uses. The Company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection.
The Company’s CODM is the Chief Executive Officer, who manages the Company’s operations based on consolidated financial information for purposes of evaluating financial performance and allocating resources. The financial information reviewed by the CODM includes revenue by product line and region, and key expense categories that are regularly provided for the consolidated company.
 
AMERICAN VANGUARD CORPORATION
 
The accounting policies of the Company’s single operating segment are the same as those described in the summary of significant accounting policies. Although there are other measures of operating performance used by the CODM, the Company concluded that consolidated operating (loss) income is the measure required to be disclosed as the segment measure of profit or loss. Operating (loss) income is utilized to evaluate to monitor budget versus actual results in order to gain more depth and understanding of the factors driving the business. When evaluating the Company’s financial performance, the following table sets forth significant expense categories regularly provided to the CODM:
 
    
2025
     
2024
     
2023
  
Net sales
    $ 515,114      $ 547,306      $ 579,371  
Cost of sales:
         
Material and other costs
      (323,939 )       (381,784 )       (354,580 ) 
Warehousing, handling, and outbound freight
      (43,614 )       (45,205 )       (45,627 ) 
  
 
 
     
 
 
     
 
 
  
Total cost of sales
      (367,553 )       (426,989 )       (400,207 ) 
Gross profit
      147,561        120,317        179,164  
Operating expenses
         
Selling, general and administrative
      (110,633 )       (119,634 )       (116,887 ) 
Research, product development and regulatory
      (23,161 )       (32,662 )       (38,025 ) 
Product liability claims
      (9,730 )       —         —   
Transformation
      (7,187 )       (20,162 )       (957 ) 
Asset impairment charges
      (25,395 )       (50,414 )       —   
Gain from sale of assets
      249        1,000        —   
  
 
 
     
 
 
     
 
 
  
Operating (loss) income
      (28,296 )       (101,555 )       23,295  
Change in fair value of equity investments, net
      (437 )       (2,356 )       (359 ) 
Interest and other expenses, net
      (18,470 )       (16,547 )       (12,639 ) 
  
 
 
     
 
 
     
 
 
  
(Loss) income before provision for income taxes
      (47,203 )       (120,458 )       10,297  
Provision for income taxes
      (2,679 )       (5,882 )       (2,778 ) 
  
 
 
     
 
 
     
 
 
  
Net (loss) income
    $ (49,882 )     $ (126,340 )     $ 7,519  
  
 
 
     
 
 
     
 
 
  
Assets provided to the CODM are consistent with those reported on the consolidated balance sheets.